United World Antiviral Research Network (UWARN)
Funded at University of Washington · NIH-11627864 · Data updated 2026-11-12
A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | May 22, 2020 |
| Project end | June 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $21,599 |
| NIH project number | 3U01AI151698-06S6 |
| Project ID | NIH-11627864 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable to a single patient group; the study involves surveillance and research across LMIC communities and may inform care for people living with HIV and other vulnerable populations.
✕Less likely to help
The work is largely focused on surveillance and public health understanding rather than direct patient treatment.
What this research studies
UWARN is a NIH-supported research center led by the University of Washington with partners in Brazil, Senegal, and Taiwan. The project uses a One Health approach to study arboviruses and coronaviruses, tracking infections in humans, animals, and the environment to understand how viruses evolve and spread. The team plans to expand to new sites in Thailand and to work on high-burden viruses like dengue, chikungunya, yellow fever, Zika, and other related viruses. Outcomes include improved viral detection, better understanding of how infections progress, and data that can guide public health responses in diverse settings. This work may inform future vaccines, diagnostics, and interventions for communities at risk.
Why it matters
Potential benefit: If successful, the project could improve detection and understanding of viral infections in high-burden regions, guiding safer practices and targeted public health actions.
How similar studies have gone: The grant cites prior discovery and tracking of SARS-CoV-2 variants and other arboviruses, indicating a track record of impactful, if broad, infectious disease research.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Rabinowitz, Peter Macgarr — University of Washington
- Study coordinator: Rabinowitz, Peter Macgarr
Related research
Other NIH-funded projects on the same topics.
-
Making genetic testing more accessible to the public
This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.
-
Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana
A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.
-
Binaural Hearing and Speech in Noise in Children
This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.
-
Neural circuits that control pain aversion in the brain
Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.
-
HF endotypes in heart failure using ethical multi-modal AI and molecular data
A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.
-
A blood protein test to quickly diagnose melioidosis
A new plasma protein test aims to rapidly identify melioidosis in people admitted with infection, helping doctors start the right treatment sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.